Astorg, a Pan-European private equity firm, is to acquire a majority stake in hg medical, a global manufacturer of complex orthopaedic implants from NORD Holding. Astorg will support hg medical’s growth both organically and through acquisitions.
Astorg, a Pan-European private equity firm, is to acquire a majority stake in hg medical, a global manufacturer of complex orthopaedic implants from NORD Holding (NORD). Astorg will support hg medical’s growth both organically and through acquisitions.
With facilities in Germany and USA, hg medical is particularly focused on systems that address lower extremities disorders. Its team of engineers and technicians offer a comprehensive range of services, including design and development, prototyping, validation, and production of complex high-quality implants.
The company is a pioneer in the extremities segment and has built an impressive track record of customer success and profitable growth through its partnerships with fast-growing challenger and blue-chip OEMs in the extremities space over the last 16 years. In 2020, hg medical was acquired by NORD and its management team, led by CEO and founder Johannes Hagenmeyer and COO Craig Bluett.
The terms of the transaction have not been disclosed.
Astorg was advised by Houlihan Lokey (M&A), Gibson, Dunn & Crutcher, Reed Smith and Kirkland & Ellis (legal), LEK (commercial), EY (financial, tax and cybersecurity), EURO Transaction Solutions (insurance) and ERM (ESG).
NORD Holding was advised by TD Cowen (M&A), Milbank (legal), Alvarez & Marsal (commercial), Deloitte (financial), Flick Gocke Schaumburg and Alvarez & Marsal (tax), and TAUW (ESG).
